MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-17-0001332
Gladly Pharmaceuticals Private Limited
Gladly Pharmaceuticals Private Limited - healthcare in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹92.63 Lakh
▲ 89% YoY
Net profit · FY 2024
₹1.82 Lakh
Net margin 2%
EBITDA · FY 2024
₹2.04 Lakh
EBITDA margin 2.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Gladly Pharmaceuticals Private Limited
Data last updated:
Gladly Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 13 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2020PTC340601. Its GSTIN is 27AAICG3361K1ZD (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santosh Kumar Mishra and Ranjana Santosh Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No D 012 Saileela Tower Vinnay Complex Nr Railway Yard, Thane, Maharashtra, India – 401203.
As per the financials filed for FY 2024, the company reported a revenue of ₹92.63 Lakh, a growth of 89% compared to the previous year. For the same year it recorded a net profit of ₹1.82 Lakh (net margin 2%) and EBITDA of ₹2.04 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 295% over three years.
Gladly Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0001332).
Company Details of Gladly Pharmaceuticals Private Limited
CIN U24110MH2020PTC340601
Registration Number 340601
Incorporation Date 13 June 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-17-0001332
Recognitions & Rankings of Gladly Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No D 012 Saileela Tower Vinnay Complex Nr Railway Yard, Thane, Maharashtra, India – 401203
- IndustryHealthcare, Preventive Health Services
Comprehensive company report
Gladly Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Gladly Pharmaceuticals Private Limited
The main business activity of Gladly Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gladly Pharmaceuticals Private Limited FY 2025 filings available
Gladly Pharmaceuticals Private Limited reported revenue of ₹92.63 Lakh (up 89% YoY) for FY 2024.
Revenue · FY 2024
₹92.63 Lakh ▲ 89%
Net profit · FY 2024
₹1.82 Lakh margin 2%
EBITDA · FY 2024
₹2.04 Lakh margin 2.2%
Compounded Annual Growth Rate (CAGR) of Gladly Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 89%
3 years · compounded
▲ 295%
EBITDA CAGR growth
1 year
▲ 109%
3 years · compounded
▲ 180%
Revenue has grown at a compounded annual rate (CAGR) of 295% over three years, including 89% growth in the latest year. EBITDA rose 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gladly Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.04 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.82 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Gladly Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.2% | •••• | •••• | •••• |
| Net Profit Margin | 2% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gladly Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Gladly Pharmaceuticals Private Limited
Gladly Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Kumar Mishra | Director | 13 Jun 2020 | 6 Years 4 Months | Current |
| Ranjana Santosh Mishra | Director | 13 Jun 2020 | 6 Years 4 Months | Current |
Peer Comparison of Gladly Pharmaceuticals Private Limited
Gladly Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Pharma Retail and Distribution, Pharmaceuticals, Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| KDC Healthcare Private Limited | ₹92.79 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Chandigarh, India |
| Consortium for Medical Research & Education Private Limited | ₹92.75 Lakh (FY 2025) | •••• | •••• | -21.0% | •••• | Delhi, India |
| Synergy Sankalp Private Limited | ₹92.74 Lakh (FY 2025) | •••• | •••• | 120.0% | •••• | Coimbatore, Tamil Nadu, India |
| Dr. Thakkar's Pharmaceuticals Private Limited | ₹92.73 Lakh (FY 2023) | •••• | •••• | -46.0% | •••• | Vadodara, Gujarat, India |
| Cartula Health India Private Limited | ₹92.71 Lakh (FY 2025) | •••• | •••• | -13.0% | •••• | Agra, Uttar Pradesh, India |
| Gladly Pharmaceuticals Private Limited this company | ₹92.63 Lakh (FY 2024) | •••• | •••• | 89.0% | •••• | Thane, Maharashtra, India |
| Uniword Marketing Private Limited | ₹92.63 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Kharar, Punjab, India |
| Arbeitt Pharmaceuticals Private Limited | ₹92.56 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Bangalore, Karnataka, India |
| Redoq Pharmacy Private Limited | ₹92.49 Lakh (FY 2025) | •••• | •••• | 2419.0% | •••• | Kolkata, West Bengal, India |
| Hubli Assisted Conception Centre Private Limited | ₹92.49 Lakh (FY 2025) | •••• | •••• | -35.0% | •••• | Hubli, Karnataka, India |
| Golden Scalpel Private Limited | ₹92.35 Lakh (FY 2025) | •••• | •••• | •••• | Lucknow, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Gladly Pharmaceuticals by revenue in the Healthcare industry (Pharma Retail and Distribution, Pharmaceuticals, Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Gladly Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gladly Pharmaceuticals Private Limited
Gladly Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Gladly Pharmaceuticals Private Limited
Gladly Pharmaceuticals Private Limited has a workforce of 0 employees as of Mar 30, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gladly Pharmaceuticals Private Limited
Gladly Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ranjana Santosh Mishra was appointed as Director on 13 Jun 2020.
AGM
Gladly Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Gladly Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Ranjana Santosh Mishra was appointed as Director.
Appointed
Santosh Kumar Mishra was appointed as Director.
Incorporation
13 Jun 2020
Gladly Pharmaceuticals Private Limited was registered on 13 Jun 2020 with Roc Mumbai Ii & aged 6 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Gladly Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gladly Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gladly Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gladly Pharmaceuticals Private Limited
Gladly Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICG3361K1ZD | Maharashtra | Active | 30 Jun 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gladly Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gladly Pharmaceuticals Private Limited
Gladly Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 13 June 2020 (6+ years old) and is registered under CIN U24110MH2020PTC340601.
Gladly Pharmaceuticals reported revenue of ₹92.63 Lakh for FY 2024 (up 89% YoY).
Gladly Pharmaceuticals has 2 current directors:
- Santosh Kumar Mishra - Director
- Ranjana Santosh Mishra - Director
Gladly Pharmaceuticals reported a net profit of ₹1.82 Lakh (net margin 2%) and EBITDA of ₹2.04 Lakh (EBITDA margin 2.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gladly Pharmaceuticals is 295% over three years. In the latest year (FY 2024) revenue rose 89%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Gladly Pharmaceuticals is 27AAICG3361K1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Gladly Pharmaceuticals is U24110MH2020PTC340601. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gladly Pharmaceuticals was incorporated on 13 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Gladly Pharmaceuticals by revenue are KDC Healthcare Private Limited, Consortium for Medical Research & Education Private Limited, Synergy Sankalp Private Limited, Dr. Thakkar's Pharmaceuticals Private Limited, Cartula Health India Private Limited and 5 more, all in the Healthcare industry (Pharma Retail and Distribution, Pharmaceuticals, Preventive Healthcare Services).
Ranjana Santosh Mishra was appointed as Director on 13 Jun 2020. Santosh Kumar Mishra was appointed as Director on 13 Jun 2020.
Yes, Gladly Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-17-0001332).